Average prices of Humira - selected countries 2017
The price for Humira in the United States was triple the price for the same drug in Germany, as of 2017. Two kits of Humira Pen (40 mg) cost an average 4,480 U.S. dollars compared to 1,570 dollars in Germany. At 1,230 dollars, the same supply was even cheaper in Switzerland, one of the most expensive countries worldwide. In general, higher drug prices are a much discussed issue in the U.S. and pharmaceutical per capita spending is significant higher here than in other developed countries.
Where Humira is used
Humira is used mostly for the treatment of rheumatoid and psoriatic arthritis. However, like many other top drugs, the range of medical conditions it can be used to treat is much larger. Thus, the drug is also used to treat Crohn’s disease, ankylosing spondylitis, ulcerative colitis, psoriasis, uveitis, and some other autoimmune diseases. Humira is administered subcutaneously via injection. It was approved for the first time in 2002 in the United States.
Humira’s impact on AbbVie
Humira is manufactured by U.S. pharmaceutical company AbbVie and generated a massive 19.9 billion U.S. dollars of total revenue during 2018. Thus, AbbVie made 60 percent of its total revenue through Humira. It was speculated if Humira would be the first drug ever to generate global sales of over 20 billion dollars. However, projections show us that this might not happen, but more likely there will be a distinct decrease in revenue until 2024.
Where Humira is used
Humira is used mostly for the treatment of rheumatoid and psoriatic arthritis. However, like many other top drugs, the range of medical conditions it can be used to treat is much larger. Thus, the drug is also used to treat Crohn’s disease, ankylosing spondylitis, ulcerative colitis, psoriasis, uveitis, and some other autoimmune diseases. Humira is administered subcutaneously via injection. It was approved for the first time in 2002 in the United States.
Humira’s impact on AbbVie
Humira is manufactured by U.S. pharmaceutical company AbbVie and generated a massive 19.9 billion U.S. dollars of total revenue during 2018. Thus, AbbVie made 60 percent of its total revenue through Humira. It was speculated if Humira would be the first drug ever to generate global sales of over 20 billion dollars. However, projections show us that this might not happen, but more likely there will be a distinct decrease in revenue until 2024.
